METABOLIC SYNDROME AND PROSTATE CANCER: A POSSIBLE LINK TO PROSTATE CANCER AGGRESSIVENESS

被引：0
|
作者：
De Nunzio, C. [1 ]
Freedland, S. J. [2 ]
Miano, R. [3 ]
Trucchi, A. [1 ]
Cantiani, A. [1 ]
Esperto, F. [1 ]
Brassetti, A. [1 ]
Tubaro, A. [1 ]
机构：
[1] Univ Roma La Sapienza, St Andrea Hosp, Dept Urol, Rome, Italy
[2] Duke Univ, Med Ctr, Duke Prostate Ctr, Dept Surg, Durham, NC 27706 USA
[3] Univ Roma Tor Vergata, Policlin Tor Vergata, Dept Urol, Rome, Italy
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2011年 / 10卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(11)60308-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [41] Risk Analysis of Prostate Cancer Treatments in Promoting Metabolic Syndrome Development and the Influence of Increased Metabolic Syndrome on Prostate Cancer Therapeutic Outcome
    Zongping Chen
    Jichun Deng
    Yong Yan
    Min Li
    Chanjuan Chen
    Chao Chen
    Sicong Zhao
    Tao Song
    Tong Liu
    Xin Wen
    Yuhong Yao
    Hormones and Cancer, 2018, 9 : 278 - 287
  • [42] Sarcosine in Prostate Cancer Tissue is Not a Differential Metabolite for Prostate Cancer Aggressiveness and Biochemical Progression
    Jentzmik, Florian
    Stephan, Carsten
    Lein, Michael
    Miller, Kurt
    Kamlage, Beate
    Bethan, Bianca
    Kristiansen, Glen
    Jung, Klaus
    JOURNAL OF UROLOGY, 2011, 185 (02): : 706 - 711
  • [43] Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer
    Fukuma, Y.
    Matsui, H.
    Koike, H.
    Sekine, Y.
    Shechter, I.
    Ohtake, N.
    Nakata, S.
    Ito, K.
    Suzuki, K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (04) : 339 - 345
  • [44] Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer
    Y Fukuma
    H Matsui
    H Koike
    Y Sekine
    I Shechter
    N Ohtake
    S Nakata
    K Ito
    K Suzuki
    Prostate Cancer and Prostatic Diseases, 2012, 15 : 339 - 345
  • [45] Cardiovascular disease risk among men with prostate cancer: Differences by prostate cancer aggressiveness
    Himbert, Caroline
    Plym, Anna
    Vaselkiv, Jane B.
    Pettersson, Andreas
    Kantoff, Philip W.
    Mucci, Lorelei A.
    Mukamal, Kenneth J.
    Stosapck, Konrad H.
    CANCER RESEARCH, 2024, 84 (06)
  • [46] The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
    Xiang, Yu-zhu
    Xiong, Hui
    Cui, Zi-lian
    Jiang, Shao-bo
    Xia, Qing-hua
    Zhao, Yong
    Li, Guan-bin
    Jin, Xun-bo
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2013, 32
  • [47] The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
    Yu-zhu Xiang
    Hui Xiong
    Zi-lian Cui
    Shao-bo Jiang
    Qing-hua Xia
    Yong Zhao
    Guan-bin Li
    Xun-bo Jin
    Journal of Experimental & Clinical Cancer Research, 32
  • [48] DNA methylation sequencing of prostate tumors: Possible molecular mechanisms for cancer aggressiveness
    Bhasin, Jeffrey M.
    Matkin, Lars
    Taylor, Margaret G.
    Lee, Byron H.
    Magi-Galluzi, Cristina
    Klein, Eric A.
    Hu, Bo
    Xu, Yaomin
    Ting, Angela H.
    CANCER RESEARCH, 2015, 75 (22)
  • [49] PROSTATE CANCER IBD as a risk factor for prostate cancer: what is the link?
    Sfanos, Karen S.
    Joshu, Corinne E.
    NATURE REVIEWS UROLOGY, 2019, 16 (05) : 271 - 272
  • [50] The metabolic syndrome is associated with reduced risk of prostate cancer
    Tande, Aaron J.
    Platz, Elizabeth A.
    Folsom, Aaron R.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 164 (11) : 1094 - 1102
12345